Dr. Sophie Chargé
BloodTechNet is a competitive funding program that supports projects aimed at delivering innovative educational resources for healthcare professionals in the transfusion, cellular therapy, and transplantation communities. Again this year, we were impressed by the quality of the applications received for the BloodTechNet competition and we look forward to seeing the educational resources that the four new projects will produce in about a year. To share our excitement, here’s a taste of what’s to come! Enhancing knowledge about blood groups and antibodies to prevent transfusion reactions The
Previous posts in our "The things we do for safety" series Battling bacteria - part I Leukoreduction In a previous post, we wrote about the donor screening criteria, the arm scrub and the diversion pouch. These are important steps in our blood collection process to limit the introduction of bacteria present on the skin or in the blood of donors into blood products. In this post, we explore other lines of defence in our battle against bacteria. The entire blood product manufacturing process is conducted in a “closed-system”. Through a clever set-up of tubings and bags, the collected blood is
A previous post in our "The things we do for safety" series explores leukoreduction - or how white blood cells or leukocytes get filtered out of blood products to reduce the risk of transfusion-related reactions. Battling bacteria (part 1) Bacteria can be found pretty much everywhere and while some contribute to our wellness others can cause serious harm, especially if transfused to a patient whose health is already compromised. Over the years, blood operators have implemented a variety of measures to limit the bacterial contamination of blood components. In this series on “Battling bacteria”
Canadian Blood Services implemented leukoreduction for the production of its red blood cells and platelet components in the late 1990s.